CELESTIMO met its primary endpoint (Sept 17): mosunetuzumab + lenalidomide beat R2 on PFS in R/R follicular lymphoma, n=478.
OS immature, HR and median PFS not released. A signal, not yet a standard.

CELESTIMO met its primary endpoint (Sept 17): mosunetuzumab + lenalidomide beat R2 on PFS in R/R follicular lymphoma, n=478.
OS immature, HR and median PFS not released. A signal, not yet a standard.
FDA cut tarlatamab's post-infusion monitoring for the first 2 doses from 22 to 24 h down to 6 to 8 h, plus a next-day check (Sept 14).
DeLLphi-304: median OS 13.6 vs 8.3 months vs chemo. This one is about access, not efficacy.
FDA approved imlunestrant + abemaciclib (Sept 18) for ER+, HER2-, ESR1-mutated advanced breast cancer after at least one line of endocrine therapy.
EMBER-3 ESR1 subgroup: median PFS 11.1 vs 5.5 months. Exploratory subgroup, n=159.
#AML #HemOnc #BoardPrep Practice question of the week. Meducation AI: 1,500+ board-style hem/onc questions plus AI-powered study tools. Free 7-day trial: meducationai.com
Med school teaches you medicine. Fellowship teaches you cancer. Who keeps you current after that? OncoPulse is a free AI agent that emails you new evidence in the cancers you treat.
Happening this Friday!
⮕ Register: hemehub.org/live-webinars
🌐 Learn more: hemehub.org
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
#GastricCancer #HemOnc #BoardPrep Boards coming up? 1,500+ board-style hem/onc questions and AI study tools for fellows at Meducation AI. Free 7-day trial: meducationai.com
How much time would it actually take to keep up with oncology research? My honest estimate is in the first ten seconds, and it's more than you'd think.
Here's the AI agent we built to shrink it, free for anyone treating cancer.
🌟 Our DLBCL case discussion with Sairah Ahmed, MD, and Elif Yilmaz, MD is now available to watch on YouTube!
⮕ Watch the full session: youtu.be/EMPaDlO5lto
Happening next Friday!
⮕ Register: hemehub.org/live-webinars
#SmolderingMyeloma #MultipleMyeloma #Myeloma #Hematology #HemOnc #Oncology #MedicalEducation #MedEd #HemeHub
#AML #HemOnc #BoardPrep Practice question of the week. For the full 1,500+ question hem/onc bank and AI study tools, visit Meducation AI. Free 7-day trial: meducationai.com
You're using 3 apps to study one topic.
A question bank. A flashcard app. Somewhere to take notes.
None of them know the others exist.
#MedEd #BoardPrep #HemOnc #OncologyFellow #HematologyFellow
🩸 Happening this Friday!
⮕ Register: hemehub.org/live-webinars
⮕ Submit your cases: hemehub.org/case-submiss...
#SmolderingMyeloma #MultipleMyeloma #Hematology #HemOnc #Oncology #MedEd #HemeHub